PW Medtech Group (FRA:PWE) Forward Dividend Yield %: 6.43% (As of Jun. 29, 2026)


FRA:PWE PW Medtech Group Ltd FRA:PWE
83 GF Score
Price €0.11
GF Value €0.13
! 5 Warning Signs
View Full Analysis

What is PW Medtech Group Forward Dividend Yield %?

PW Medtech Group FRA:PWE 83 Forward Dividend Yield % is 6.43% as of Jun. 29, 2026. GuruFocus rates FRA:PWE with a GF Score™ of 83/100 and a GF Value™ of €0.13. The stock has 5 warning signs investors should review. Among 315 Medical Devices & Instruments companies, PW Medtech Group ranks better than 91.75% on this metric.

As of today (2026-06-29), the Forward Annual Dividend Yield of PW Medtech Group is 6.43%.

As of today (2026-06-29), the Trailing Annual Dividend Yield of PW Medtech Group is 9.64%.

FRA:PWE's Forward Dividend Yield % is ranked better than
91.75% of 315 companies
in the Medical Devices & Instruments industry
Industry Median: 2.15 vs FRA:PWE: 6.43

PW Medtech Group's Dividends per Share for the six months ended in Dec. 2025 was €0.01.

During the past 12 months, PW Medtech Group's average Dividends Per Share Growth Rate was 5.40% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


PW Medtech Group  (FRA:PWE) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


PW Medtech Group Forward Dividend Yield % Related Terms


FRA:PWE vs ISRG, BDX, MDLN: Forward Dividend Yield % Comparison

For the Medical Instruments & Supplies subindustry, PW Medtech Group's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PW Medtech Group Forward Dividend Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PW Medtech Group's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where PW Medtech Group's Forward Dividend Yield % falls into.


FRA:PWE
83GF Score
PW Medtech Group Ltd FRA:PWE
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PW Medtech Group Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

PW Medtech Group Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
HKD 0.0440002025-11-032025-11-052025-12-03Cash Dividendsemi-annuallyHKD:EUR 0.111098
HKD 0.0530002025-07-032025-07-072025-07-25Cash Dividendsemi-annuallyHKD:EUR 0.109173

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

PW Medtech Group's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=0.009776624/0.11
=8.89 %

Current Share Price is €0.11.
PW Medtech Group's Dividends per Share for the forward twelve months is calculated as €0.004888312 * 2 = €0.009776624.

PW Medtech Group's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=0.010674481/0.11
=9.70 %

Current Share Price is €0.11.
PW Medtech Group's Dividends per Share for the trailing twelve months (TTM) ended in Today is €0.010674481.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Forward Dividend Yield % of 6.43% mean?
PW Medtech Group (FRA:PWE) has a Forward Dividend Yield % of 6.43% as of Jun. 29, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on PW Medtech Group and its competitors. According to the industry distribution chart, PW Medtech Group ranks #26 out of 315 companies in the Medical Devices & Instruments industry, placing it in the top 8.3%.
Is PW Medtech Group's Forward Dividend Yield % too high?
PW Medtech Group's current Forward Dividend Yield % is 6.43%. The Medical Devices & Instruments industry median Forward Dividend Yield % is 2.15. PW Medtech Group's value of 6.43% is 199.1% above this industry median. Based on the distribution chart, PW Medtech Group ranks #26 out of 315 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, PW Medtech Group has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does PW Medtech Group's Forward Dividend Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, PW Medtech Group ranks #26 out of 315 companies for Forward Dividend Yield %. This places PW Medtech Group in the top 8% of its industry — outperforming the majority of peers. The industry median Forward Dividend Yield % is 2.15. PW Medtech Group's value of 6.43% is 199.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Devices & Instruments company?
The median Forward Dividend Yield % among Medical Devices & Instruments companies is 2.15, based on 315 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PW Medtech Group's current Forward Dividend Yield % of 6.43% is 199.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on PW Medtech Group and its competitors. For the Medical Devices & Instruments industry, the median Forward Dividend Yield % is 2.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PW Medtech Group's current Forward Dividend Yield % is 6.43%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PW Medtech Group stock overvalued right now?
PW Medtech Group (FRA:PWE) has a current Forward Dividend Yield % of 6.43%. The stock's GF Value™ is €0.13, compared to a current price of €0.11 — trading 15.4% below its estimated fair value. The current Forward Dividend Yield % is 6.43% and 199.1% above the Medical Devices & Instruments industry median of 2.15. PW Medtech Group's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For PW Medtech Group (FRA:PWE), the current Forward Dividend Yield % is 6.43% as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PW Medtech Group (FRA:PWE) Overvalued in 2026?

Based on GuruFocus' analysis, PW Medtech Group stock appears to be undervalued. The current stock price of €0.11 is trading 15.4% below its estimated GF Value™ of €0.13.

Key valuation signals for FRA:PWE:

  • Forward Dividend Yield %: 6.43%
  • GF Value™: €0.13 vs. price of €0.11 (15.4% below fair value)
  • GF Score™: 83/100 with 5 warning signs
  • Industry Position: 199.1% above the Medical Devices & Instruments median (#26 of 315)

No single metric tells the full story. See the FRA:PWE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PW Medtech Group Business Description

Other Exchanges 01358:Hong Kong
Address No. 23 Panlong West Road, Building 1, Pinggu District, Beijing, CHN, 101204
PW Medtech Group Ltd is a medical device company focused on China's medical device industry. The Group operates in infusion sets, blood purification products, and regenerative medical biomaterials. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, insulin needles and pens, high flux and low flux hemodialyzers, hemodiafilters, hemoperfutors, and dialysis machines. Its segments are Infusion Set Business, Blood Purification Business, which represents the R&D, manufacturing, and sales of hemodialysis and blood purification medical devices, and Regenerative Medical Biomaterials Business, which generates maximum revenue. Geographically, it operates in China, North America, India and Others.
83GF Score

Get the complete analysis for FRA:PWE

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.11
Price
€0.13
GF Value